J. Purvis
-
- Cancer Treatment and Pharmacology 6
-
- Glioma Diagnosis and Treatment 3
- BRCA gene mutations in cancer 2
- Ophthalmology top 10%
-
- Renal cell carcinoma treatment 3
- Gastric Cancer Management and Outcomes 3
- Advanced Breast Cancer Therapies 2
- Metastasis and carcinoma case studies 2
-
- Health Systems, Economic Evaluations, Quality of Life 3
- Co-authors
- Ronald M. BukowskiJames K. WeickG. Thomas BuddK. ShepardRafael E. CurielJanet DanceyRobin Lin MillerRam Ganapathi
- Cited by
- OncologyGeneticsOphthalmology
- Journals
- Journal of Clinical Oncology (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)Cancer (1 paper)
- Partner nations
- United StatesNetherlandsCanada
In The Last Decade
J. Purvis
27 papers receiving 424 citations
Peers
Comparison fields: 5 of 77
- Oncology 187
- Genetics 56
- Ophthalmology 37
- Toxicology 10
- Pulmonary and Respiratory Medicine 83
Countries citing papers authored by J. Purvis
This map shows the geographic impact of J. Purvis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Purvis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Purvis more than expected).
Fields of papers citing papers by J. Purvis
This network shows the impact of papers produced by J. Purvis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Purvis. The network helps show where J. Purvis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside J. Purvis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 1 | |
| 3 | 2012 | 6 | |
| 4 | 2011 | 1 | |
| 5 | 2010 | 27 | |
| 6 | 2009 | 42 | |
| 7 | 2009 | 4 | |
| 8 | 2009 | 1 | |
| 9 | Phase I pharmacokinetic study of the novel antitumor agent SR233377. | 2000 | 17 |
| 10 | 1999 | 25 | |
| 11 | 1992 | 5 | |
| 12 | 1990 | 0 | |
| 13 | 1988 | 112 | |
| 14 | 1988 | 4 | |
| 15 | 1987 | 2 | |
| 16 | Magnetic Resonance with Marked T2-Weighted Images: Improved Demonstration of Brain Lesions, Tumor, and Edema | 1985 | 7 |
| 17 | 1985 | 36 | |
| 18 | Aggressive doxorubicin-containing regimen (prednisone, methotrexate, 5-FU, doxorubicin, and cyclophosphamide; PM-FAC) in disseminated estrogen receptor-negative breast cancer. | 1984 | 2 |
| 19 | 1983 | 20 | |
| 20 | Phase II study of PALA in advanced large bowel carcinoma. | 1981 | 9 |
About J. Purvis
J. Purvis is a scholar working on Genetics, Transplantation, Gastroenterology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 28 papers that have together received 437 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), Renal cell carcinoma treatment (3 papers), Glioma Diagnosis and Treatment (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Gastric Cancer Management and Outcomes (3 papers), Advanced Breast Cancer Therapies (2 papers), BRCA gene mutations in cancer (2 papers) and Metastasis and carcinoma case studies (2 papers). The work is most often cited by research in Oncology (187 citations), Genetics (56 citations), Ophthalmology (37 citations), Toxicology (10 citations) and Pulmonary and Respiratory Medicine (83 citations). J. Purvis has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Ronald M. Bukowski, James K. Weick, G. Thomas Budd, K. Shepard, Rafael E. Curiel, Janet Dancey, Robin Lin Miller, Ram Ganapathi, K.K. Midha and Lisa R. Rogers. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Cancer, British Journal of Cancer and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.